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UAE. The authors have no financial interest in the study.Hatem A. Tawfik a,⇑, Mohsen Mostafa bAbstractPurpose: The purpose of the current investigation was to make an objective controlled comparison of pain tolerance, patient
satisfaction and potential complications during the injection of local anesthesia in oculoplastic procedures under short-term
sedation using inhalational versus parenteral sedatives.
Methods: This was an open-label, randomized clinical trial where patients were randomized to 3 groups. Group I: Sedation with
intravenous propofol. Group II: Sedation with inhaled sevoflurane. Group 3: Control group receiving no sedation.
Results: A total of 396 patients were randomly assigned, and 375 were included in the final analysis. Study groups were similar in
age, gender, and distribution of operative procedures performed. There was no statistically significant difference in the adjusted
primary composite outcome measure between propofol and sevoflurane (pain scores and patient satisfaction). Significantly more
patients in group I required restraining during periocular injections than group II or III (p < 0.001). Significantly more patients
sneezed in group I than group II (p < 0.001) and none in the control group. Three patients in group II suffered severe
excitation–disinhibition during emergence from sedation which was rapidly reversible, and 3 more suffered a severe bout of
postoperative nausea and vomiting (PONV).
Conclusion: Sevoflurane and propofol during periocular anesthetic injections produce an equally favorable experience.
Sevoflurane is introduced painlessly, and offers better patient control with less induction of the sneezing reflex which may provide
a higher safety profile, however short-term aggression/disinhibition and PONV may be an issue in some patients.
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To date the ideal preoperative sedative drug is still
elusive. An ideal sedative should be introduced painlessly,
should have a rapid onset of action, minimal side effects,
and speedy recovery and should not lead to intraoperative
behavioral disturbances.1 The most commonly usedsedatives in oculoplastic procedures nowadays are propofol,
midazolam, and alfentanil alone or in combination.2–8
We hypothesized that volatile anesthetics might fulfill the
criteria of the ‘ideal sedative’ in an oculoplastic setting, and
to test our hypothesis we designed a 3-arm randomized
study to compare sevoflurane versus propofol with no
sedation as the control group. To the best of our knowledge,e:
al.com
u Dhabi,
Sevoflurane versus propofol sedation during anesthetic injections 127studies evaluating the use of inhalational anesthetics during
periocular injections for ophthalmic or oculoplastic proce-
dures have not been previously conducted.
Materials and methods
Participants
All consenting adult patients undergoing elective oculo-
plastic procedures during the period between September
2010 and May 2012 in 3 Ophthalmology centers were
enrolled. After institutional review board certification, all
patients were given a written informed consent. Exclusion
criteria included patients under 18 years or older than 75,
patients refusing to sign the consent, pregnancy, dementia,
known psychiatric disorders, hepatic or pancreatic insuffi-
ciency, patients with a know history of habitual drug or alco-
hol abuse, patients who underwent any surgical procedure
under local anesthesia in the past 3 years, patients with a
known allergy, or sensitivity to volatile anesthetics or to
propofol, and patients undergoing any bilateral procedures.
Study design
This was an open-label, multi-center, three-arm parallel
group, randomized controlled study comparing 2 different
methods of preoperative sedation during the injection of local
anesthetics in oculoplastic procedures with a no-treatment
(no sedation) concurrent control group as the third arm of
the study. Randomization was carried out prior to starting
the study with an online computer generated list.
Anesthesia technique
No preoperative medications or antiemetics were given to
any patient. Inside the operating room (OR), patients were
monitored with an electrocardiograph, non invasive arterial
blood pressure and pulse oximetry. In groups I and III, an
intravenous (IV) access line was placed in all patients followed
in group I by an injection of an IV bolus of 0.5 mg/kg propofol
premixed with lidocaine (2 mL, 2% lidocaine is mixed with
each 20 mL syringe of propofol).
In group II the patient was asked to firmly hold the face
mask herself under close observation from the attending
anesthesiologist, breath heavily through the mouth and
count till 10. The face mask was connected to a semi-closed
anesthetic unit, with sevoflurane 8% mixed with oxygen at a
fresh gas flow rate of 6 L/min. Inadequate sedation was
managed by maintaining mask application until the desired
effect is reached. In group II an IV access line was placed after
abolishment of the lash reflex immediately before injection of
the local anesthetic.
In arms I and II local anesthetic injections were given
immediately after confirmation of abolishment of the eyelash
reflex.
Data collection
An independent observer not involved in the study col-
lected data during the induction process and filled the ques-
tionnaire with the patients after the surgery in the outpatient
recovery room. Inside the OR, vital data were monitored andrecorded by the anesthesiologist in charge, the level of seda-
tion was noted by using a simplified sedation score devised
by Epstein et al. 9 Additional data included the degree of
co-operation of the patient under sedation, presence or
absence of sneezing, and his/her behavior during recovery.
In postoperative holding area, patients were asked to rate
their pain between 1 and 10 with 0 being the least pain and
10 being severe intolerable pain. To assess the level of recall,
patients were asked if they remembered any details while
they were sedated, and whether they were satisfied with
experience overall or not?Statistical analysis
Statistical analysis was done with the SPSS software
version 21 for Windows (IBM Corporation, New York, United
States). Pairwise comparisons were carried out using the
Student t-test for equality of means (equal variance not
assumed) for continuous variables, and Fisher’s exact test
for categorical variables (age, type of procedure, percentage
of sneezers, patient satisfaction, etc.). We integrated
average pain scores and overall patient satisfaction as a
composite outcome measure. We also set several secondary
outcome measures for evaluation including sedation score,
recovery behavioral scale, the level of cooperation during
anesthetic injections, the rate of induction of the sneezing
reflex, and finally patients’ recollection of the events. p values
were calculated as 2-tailed values. A p value less than 0.05
was considered statistically significant.Results
A total of 396 patients were randomly assigned and 375
were included in the final analysis. There were 124 patients
in group I, 128 in group II, and 123 in group III. Table 1
summarizes the baseline data. Age, gender, the type of the
procedure, and Spo2 were homogenously distributed and
were not statistically different among the 3 groups.
No difference was noted between propofol and sevoflu-
rane in pain scores (p 0.192), sedation scores (p 0.282), or
recovery behavior scale (p 0.347). Although sevoflurane
patients achieved a lower average recovery behavior scale,
3 patients from this group suffered a brief but severe bout
of emergence delirium (ED) during recovery from sedation
which was not expected and therefore not accounted for sta-
tistically. Two of them had severe hyperexcitability (laughter
episode) while the third suffered hysterical crying. All 3
patients had no later recollection of these events.
When we evaluated the adjusted primary outcome mea-
sure, both sedation groups fared well (p 0.222) but each
fared better than the control group (p < 0.001). Significantly
more propofol patients were restrained during sedation than
sevoflurane and even the control group (p < 0.001). There
were significantly more sneezers in group I than in group II
(p < 0.001), but the control group had no sneezers and
performed better than the 2 study groups (p < 0.001).
In the outpatient recovery room, both treatment
modalities impaired memory, but more patients in group I
claimed remembering OR events, however this did not reach
statistical significance (p 0.0986). Awareness and recall with
propofol as well as sevoflurane sedation, and even with the
Table 1. Baseline data are expressed in means, standard deviation and percentages.
Group I Group II Group III
Propofol Sevoflurane No sedation
N, 124 N, 128 N, 123
Age, mean (SD) 45.7(15.4) 43(17.2) 44.7(19.2)
Women, n (%) 74(59) 70(54) 71(57)
Minor procedures, n (%) 78(62) 77(60) 75(60)
Spo2 97.69(0.47) 97.75(0.42) 97.6(0.65)
128 HA Tawfik, M. Mostafause of propofol during total IV anesthesia has been reported
before.10–12
Slightly more patients in group I were satisfied with the
sedation type than group II or the control group but this
did not reach statistical significance except when group I
was paired with the control group (p 0.0049). Three patients
in group II suffered severe postoperative nausea and vomit-
ing (PONV) in the recovery room.
Eight patients from group I voiced their discontent
because of the pain associated with cannula placement. Four
patients in group II were annoyed with the mask placed on
their face, and one patient from group II recalled a repugnant
smell from the mask. Five patients from the control group
mentioned that the experience could have been better if they
were ‘asleep’ during the injections. The main effects of treat-
ment are summarized in Tables 2 and 3.
Discussion
Intravenous medications have been the mainstay of seda-
tion to alleviate patients’ anxiety during periocular anesthetic
injections. Drugs like propofol, ketamine, alfentanil andTable 2. Primary and secondary outcome measures. Data are expressed in me
Group I
Propofol
N, 124
Pain score#, mean (SD) 0.148(0.
Sedation score, mean (SD) 4.1(0.88
Cooperative scale, mean (SD) 1.7(0.7)
Recovery behavior scale, mean (SD) 1.31(0.5
Sneezers, n (%) 33(26)
Patient remembers, n (%) 7(8)
Satisfied patients, n (%)* 117(94)
Adjusted primary composite index, mean (SD) 0.940(0.
# Measurements are made with the VAS or the numerical score depending on patients’
* Percentage of satisfied patients is calculated here as a categorical value, but was conv
Table 3. Pairwise comparisons of baseline data, intraoperative and postope
expressed in p values.
Group I, II
p value
Age 0.18513
Women 0.4469
Minor procedures 0.6985
Spo2 0.647
Pain score 0.192
Sedation score 0.282
Cooperative scale p < 0.001
Recovery behavior scale 0.34711
Sneezers p < 0.001
Patient remembers 0.0986
Satisfied patients 0.1715
Adjusted primary composite index 0.222midazolam have been used alone or in combination,2–6 with
propofol usually claiming the lion’s share.3,6 Despite the pop-
ularity of propofol, questions have always been raised about
its potential safety particularly the risk of sneezing which
could theoretically lead to catastrophic ocular complica-
tions.3–6 Interestingly, despite extensive discussion in the
general medical literature,13–22 the pros and cons of IV seda-
tion using propofol versus inhaled sedation have never been
studied in the ophthalmic literature. Sevoflurane, one of the
relatively newer inhalational anesthetics is a sweet-smelling,
nonflammable, highly fluorinated anesthetic providing fast
induction, potent hypnosis and speedy recovery with lower
accumulation in the tissues and minimal irritation of the
mucous membranes,23–25 and therefore our hypothesis was
that it might fulfill the criteria for the ideal sedative, however,
as evidenced by our adjusted primary composite outcome
measure neither sedative confers any statistical advantage
over the other. A closer look at the secondary outcome mea-
sures will tell a different story. Two powerful trends where
sevoflurane proved to be superior to propofol is better con-
trol (lesser patient movements) during anesthetic injections
and less sneezing.ans, standard deviation and percentages.
Group II Group III
Sevoflurane No sedation control
N, 128 N, 123
57) 0.073(0.26) 2.36(2.37)
2) 3.98(0.891) –
1.21(0.48) 1.27(0.63)
3) 1.24(0.61) –
3(2.3) 0(0)
2(1.5) 110(89)
114(92.6) 102(82)
314) 0.944(0.226) 0.824(0.1167)
education level.
erted into integers when we adjusted to calculate the primary composite measure.
rative sedation profiles for propofol, sevoflurane and the control group
Group I, III Group II,III
p value p value
0.63717 0.46422
0.79 0.7028
0.4367 0.7940
0.637 0.906
p < 0.001 p < 0.001
– –
p < 0.001 0.385
– –
p < 0.001 p < 0.001
p < 0.001 p < 0.001
0.0049 0.2022
p < 0.001 p < 0.001
Sevoflurane versus propofol sedation during anesthetic injections 129Patient movement under propofol sedation with or with-
out globe perforation has been documented before and is
significantly reduced with the addition of remifentanil.7,26
The rate of sneezing in the propofol group was 26% which
is comparable to previous studies related to propofol use
where the rate of sneezing varied from as high as 43.6% 5
to as low as 5%.3 To our surprise, 3 patients from the sevoflu-
rane group suffered a vigorous sneezing episode. This find-
ing is unusual as it has never been reported before and
neither the manufacturer nor the FDA list sneezing as one
of the potential side effects of sevoflurane, and it lends cre-
dence to the notion that drugs other than propofol may also
induce sneezing.5
Sevoflurane is associated with some unique problems of
its own which were not accounted for in our statistical analy-
sis. Three patients suffered a severe episode of emergence
delirium (ED) after recovering from the effect of sevoflurane.
Fortunately the episodes were short ranging from 2 to 3 min
and patients had no memory of the event thereafter. ED
which is also referred to as emergence agitation is a well-
known side effect of sevoflurane when used as a general
anesthetic particularly in the pediatric population but has
rarely been reported in adults receiving anesthetic doses of
the drug.27 To the best of our knowledge, this is the first time
ED has ever been documented in adults receiving a sedative
dose of sevoflurane.
In conclusion both agents provide comparable results
regarding the depth of sedation, pain control and overall sat-
isfaction, but sevoflurane could deliver a better safety profile
as a short-term sedative for patients receiving periocular
anesthetics without the need for a prior IV access line and
with minimal and partly preventable side effects which only
occurred after and not during the administration of
anesthetic injections.Conflict of interest
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